FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Carmell Therapeutics Corporation Stock AnalysisComprehensive stock analysis for Carmell Therapeutics Corporation (CTCX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCTCX
CTCX
Carmell Therapeutics Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CTCX
Home🔹Stocks🔹Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX•NASDAQ

Carmell Therapeutics Corporation

CTCX•NASDAQ
Market cap
$5.94M
Sentiment

Your view on CTCX

Mkt Cap
$5.94M
Sentiment
Your view
CTCX
Carmell Therapeutics Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CTCX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Carmell Therapeutics Corporation

Industry
Biotechnology
Sector
Healthcare
CEO
Rajiv Sarman Shukla
Headquarters
US
Industry
Biotechnology
Sector
Healthcare
CEO
Rajiv Sarman Shukla
Headquarters
US
Description

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News